Home › Trial NCT00953849
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity
- Trial IDNCT00953849
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorVA Office of Research and Development
- Enrollment21
- Start date2009-11
- ConditionsMouth Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.